(Q50754968)

English

Point-counterpoint. Mass population skin cancer screening is not worthwhile.

scientific article published in January 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

title

Point-counterpoint. Mass population skin cancer screening is not worthwhile. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

1 reference

R H Rampen

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

publication date

1 January 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

published in

Journal of cutaneous medicine and surgery

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

page(s)

128-129

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

cites work

Screening for melanoma and options for its evaluation [see comment].

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F120347549800200302

retrieved

21 January 2018

Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F120347549800200302

retrieved

21 January 2018

False-negative findings in skin cancer and melanoma screening.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F120347549800200302

retrieved

21 January 2018

Skin cancer screening focusing on melanoma yields more selective attendance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F120347549800200302

retrieved

21 January 2018

Identifiers

DOI

10.1177/120347549800200302

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

PubMed publication ID

9556369

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9556369

retrieved

18 March 2018

reference URL

http://europepmc.org/abstract/MED/9556369

(Q50754968)

Point-counterpoint. Mass population skin cancer screening is not worthwhile.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)